Erik Ames

Title(s)Assistant Clinical Professor, Pathology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0002-4522-7319 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment. Int Rev Cell Mol Biol. 2022; 370:65-122. Dunai C, Ames E, Ochoa MC, Fernandez-Sendin M, Melero I, Simonetta F, Baker J, Alvarez M. PMID: 35798507.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    2. Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturer. Clin Chem Lab Med. 2022 06 27; 60(7):e159-e160. Ames E, Bowen RAR. PMID: 35405044.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Polytypic T-cell prolymphocytic leukemia. Blood. 2021 04 15; 137(15):2125. Ames E, Silva O. PMID: 33856441.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells. Cancers (Basel). 2019 Jan 14; 11(1). Luna JI, Grossenbacher SK, Sturgill IR, Ames E, Judge SJ, Bouzid LA, Darrow MA, Murphy WJ, Canter RJ. PMID: 30646520; PMCID: PMC6356940.
      View in: PubMed   Mentions: 12  
    5. Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroid. Diagn Cytopathol. 2018 Jul; 46(7):632-635. Ames E, Campbell MJ, Afify A, Krane JF, Huang EC. PMID: 29479842.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    6. Immune targeting of cancer stem cells in gastrointestinal oncology. J Gastrointest Oncol. 2016 Apr; 7(Suppl 1):S1-S10. Canter RJ, Grossenbacher SK, Ames E, Murphy WJ. PMID: 27034806; PMCID: PMC4783622.
      View in: PubMed   Mentions: 6  
    7. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. J Immunol. 2015 Oct 15; 195(8):4010-9. Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ. PMID: 26363055; PMCID: PMC4781667.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansAnimalsCells
    8. Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity. Immunity. 2015 Aug 18; 43(2):240-50. Sckisel GD, Bouchlaka MN, Monjazeb AM, Crittenden M, Curti BD, Wilkins DE, Alderson KA, Sungur CM, Ames E, Mirsoian A, Reddy A, Alexander W, Soulika A, Blazar BR, Longo DL, Wiltrout RH, Murphy WJ. PMID: 26231116; PMCID: PMC4770886.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    9. Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells. Oncoimmunology. 2015 Sep; 4(9):e1036212. Ames E, Canter RJ, Grossenbacher SK, Mac S, Smith RC, Monjazeb AM, Chen M, Murphy WJ. PMID: 26405602; PMCID: PMC4570100.
      View in: PubMed   Mentions: 46     Fields:    
    10. Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma. BMC Cancer. 2014 Oct 10; 14:756. Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ. PMID: 25301268; PMCID: PMC4200119.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    11. The authors' reply. Transplantation. 2014 Sep 15; 98(5):e39-40. Ames E, Murphy WJ. PMID: 25171530; PMCID: PMC4343530.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    12. Treatment of chronic graft-versus-host disease with bortezomib. Blood. 2014 Sep 04; 124(10):1677-88. Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Jagdeo J, Blazar BR, Murphy WJ, Abedi M. PMID: 25009225; PMCID: PMC4155274.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCellsCTClinical Trials
    13. Natural killer cell subsets differentially reject embryonic stem cells based on licensing. Transplantation. 2014 May 27; 97(10):992-8. Perez-Cunningham J, Ames E, Smith RC, Peter AK, Naidu R, Nolta JA, Murphy WJ. PMID: 24704665.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    14. Advantages and clinical applications of natural killer cells in cancer immunotherapy. Cancer Immunol Immunother. 2014 Jan; 63(1):21-8. Ames E, Murphy WJ. PMID: 23989217; PMCID: PMC3880590.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    15. Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance. J Immunol. 2013 Jul 15; 191(2):688-98. Alvarez M, Sungur CM, Ames E, Anderson SK, Pomeroy C, Murphy WJ. PMID: 23752612; PMCID: PMC3733663.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    16. Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc Natl Acad Sci U S A. 2013 Apr 30; 110(18):7401-6. Sungur CM, Tang-Feldman YJ, Ames E, Alvarez M, Chen M, Longo DL, Pomeroy C, Murphy WJ. PMID: 23589894; PMCID: PMC3645578.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    17. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation. J Immunol. 2012 Aug 15; 189(4):2033-42. Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai CC, Chen M, Blazar BR, Abedi M, Murphy WJ. PMID: 22778394; PMCID: PMC3509544.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    18. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy. Blood. 2012 Mar 29; 119(13):3073-83. Tietze JK, Wilkins DE, Sckisel GD, Bouchlaka MN, Alderson KL, Weiss JM, Ames E, Bruhn KW, Craft N, Wiltrout RH, Longo DL, Lanier LL, Blazar BR, Redelman D, Murphy WJ. PMID: 22251483; PMCID: PMC3321869.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    19. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. Blood. 2012 Feb 09; 119(6):1590-8. Sun K, Alvarez M, Ames E, Barao I, Chen M, Longo DL, Redelman D, Murphy WJ. PMID: 22184406; PMCID: PMC3286220.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    20. The triterpenoid CDDO-Me promotes hematopoietic progenitor expansion and myelopoiesis in mice. Biol Blood Marrow Transplant. 2012 Mar; 18(3):396-405. Ames E, Harouna S, Meyer C, Welniak LA, Murphy WJ. PMID: 22100978; PMCID: PMC3502000.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    21. Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC. Blood. 2011 Jun 30; 117(26):7032-41. Barao I, Alvarez M, Ames E, Orr MT, Stefanski HE, Blazar BR, Lanier LL, Anderson SK, Redelman D, Murphy WJ. PMID: 21498673; PMCID: PMC3143551.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    22. Sensitization of human breast cancer cells to natural killer cell-mediated cytotoxicity by proteasome inhibition. Clin Exp Immunol. 2009 Mar; 155(3):504-13. Ames E, Hallett WH, Murphy WJ. PMID: 19220837; PMCID: PMC2669527.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    23. Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses. Biol Blood Marrow Transplant. 2008 Oct; 14(10):1088-1099. Hallett WHD, Ames E, Álvarez M, Barao I, Taylor PA, Blazar BR, Murphy WJ. PMID: 18804038; PMCID: PMC2735407.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    24. Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. J Immunol. 2008 Jan 01; 180(1):163-70. Hallett WH, Ames E, Motarjemi M, Barao I, Shanker A, Tamang DL, Sayers TJ, Hudig D, Murphy WJ. PMID: 18097016.
      View in: PubMed   Mentions: 77     Fields:    Translation:AnimalsCells